Khang Wen Goh

Dr. Khang Wen Goh


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2022 in Cancers
Verified
Journal Article
Open access
PDF file
Md. Sanower HossainMd. Sanower Hossain
Md. Sanower Hossain
Hidayah KaruniawatiHidayah Karuniawati
Hidayah Karuniawati
AJAmmar Jairoun
Ammar Jairoun
ZUZannat Urbi
Zannat Urbi
DODer Jiun Ooi
Der Jiun Ooi
MHMuhammad Abdul Hadi
Muhammad Abdul Hadi
Colorectal cancer (CRC) is the second most deadly cancer. Global incidence and mortality are likely to be increased in the coming decades. Although the deaths associated with CRC are very high in high-income countries, the incidence and fatalities related to CRC are growing in developing countries too. CRC detected early is entirely curable by surgery and subsequent medications. However, the recurrence rate is high, and cancer drug resistance increases the treatment failure rate. Access to early diagnosis and treatment of CRC for survival is somewhat possible in developed countries. However, these facilities are rarely available in developing countries. Highlighting the current status of CRC, its development, risk factors, and management is crucial in creating public awareness. Therefore, in this review, we have comprehensively discussed the current global epidemiology, drug resistance, challenges, risk factors, and preventive and treatment strategies of CRC. Additionally, there is a brief discussion on the CRC development pathways and recommendations for preventing and treating CRC.

16 September 2020 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
Long MingLong Ming
Long Ming
NUNoorazrina Untong
Noorazrina Untong
NANur Amalina Aliudin
Nur Amalina Aliudin
NONorliza Osili
Norliza Osili
Nurolaini KifliNurolaini Kifli
Nurolaini Kifli
HGHui Poh Goh
Hui Poh Goh
Background: Mobile health (mHealth) app use is a major concern because of the possible dissemination of misinformation that could harm the users. Particularly, it can be difficult for health care professionals to recommend a suitable app for coronavirus disease (COVID-19) education and self-monitoring purposes. Objective: This study aims to analyze and evaluate the contents as well as features of COVID-19 mobile apps. The findings are instrumental in helping health care professionals to identify suitable mobile apps for COVID-19 self-monitoring and education. The results of the mobile apps’ assessment could potentially help mobile app developers improve or modify their existing mobile app designs to achieve optimal outcomes. Methods: The search for the mHealth apps available in the android-based Play Store and the iOS-based App Store was conducted between April 18 and May 5, 2020. The region of the App Store where we performed the search was the United States, and a virtual private network app was used to locate and access COVID-19 mobile apps from all countries on the Google Play Store. The inclusion criteria were apps that are related to COVID-19 with no restriction in language type. The basic features assessment criteria used for comparison were the requirement for free subscription, internet connection, education or advisory content, size of the app, ability to export data, and automated data entry. The functionality of the apps was assessed according to knowledge (information on COVID-19), tracing or mapping of COVID-19 cases, home monitoring surveillance, online consultation with a health authority, and official apps run by health authorities. Results: Of the 223 COVID-19–related mobile apps, only 30 (19.9%) found in the App Store and 28 (44.4%) in the Play Store matched the inclusion criteria. In the basic features assessment, most App Store (10/30, 33.3%) and Play Store (10/28, 35.7%) apps scored 4 out of 7 points. Meanwhile, the outcome of the functionality assessment for most App Store apps (13/30, 43.3%) was a score of 3 compared to android-based apps (10/28, 35.7%), which scored 2 (out of the maximum 5 points). Evaluation of the basic functions showed that 75.0% (n=36) of the 48 included mobile apps do not require a subscription, 56.3% (n=27) provide symptom advice, and 41.7% (n=20) have educational content. In terms of the specific functions, more than half of the included mobile apps are official mobile apps maintained by a health authority for COVID-19 information provision. Around 37.5% (n=18) and 31.3% (n=15) of the mobile apps have tracing or mapping and home monitoring surveillance functions, respectively, with only 17% (n=8) of the mobile apps equipped with an online consultation function. Conclusions: Most iOS-based apps incorporate infographic mapping of COVID-19 cases, while most android-based apps incorporate home monitoring surveillance features instead of providing focused educational content on COVID-19. It is important to evaluate the contents and features of COVID-19 mobile apps to guide users in choosing a suitable mobile app based on their requirements.

27 September 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
BSBAKRIM SAAD
BAKRIM SAAD
Nesrine BenkhairaNesrine Benkhaira
Nesrine Benkhaira
IBIlhame BOURAIS
Ilhame BOURAIS
TBTaoufiq Benali
Taoufiq Benali
Learn-Han LeeLearn-Han Lee
Learn-Han Lee
Abdelhakim BOUYAHYAAbdelhakim BOUYAHYA
Abdelhakim BOUYAHYA
Stigmasterol is an unsaturated phytosterol belonging to the class of tetracyclic triterpenes. It is one of the most common plant sterols, found in a variety of natural sources, including vegetable fats or oils from many plants. Currently, stigmasterol has been examined via in vitro and in vivo assays and molecular docking for its various biological activities on different metabolic disorders. The findings indicate potent pharmacological effects such as anticancer, anti-osteoarthritis, anti-inflammatory, anti-diabetic, immunomodulatory, antiparasitic, antifungal, antibacterial, antioxidant, and neuroprotective properties. Indeed, stigmasterol from plants and algae is a promising molecule in the development of drugs for cancer therapy by triggering intracellular signaling pathways in numerous cancers. It acts on the Akt/mTOR and JAK/STAT pathways in ovarian and gastric cancers. In addition, stigmasterol markedly disrupted angiogenesis in human cholangiocarcinoma by tumor necrosis factor-α (TNF-α) and vascular endothelial growth factor receptor-2 (VEGFR-2) signaling down-regulation. The association of stigmasterol and sorafenib promoted caspase-3 activity and down-regulated levels of the anti-apoptotic protein Bcl-2 in breast cancer. Antioxidant activities ensuring lipid peroxidation and DNA damage lowering conferred to stigmasterol chemoprotective activities in skin cancer. Reactive oxygen species (ROS) regulation also contributes to the neuroprotective effects of stigmasterol, as well as dopamine depletion and acetylcholinesterase inhibition. The anti-inflammatory properties of phytosterols involve the production of anti-inflammatory cytokines, the decrease in inflammatory mediator release, and the inhibition of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). Stigmasterol exerts anti-diabetic effects by reducing fasting glucose, serum insulin levels, and oral glucose tolerance. Other findings showed the antiparasitic activities of this molecule against certain strains of parasites such as Trypanosoma congolense (in vivo) and on promastigotes and amastigotes of the Leishmania major (in vitro). Some stigmasterol-rich plants were able to inhibit Candida albicans, virusei, and tropicalis at low doses. Accordingly, this review outlines key insights into the pharmacological abilities of stigmasterol and the specific mechanisms of action underlying some of these effects. Additionally, further investigation regarding pharmacodynamics, pharmacokinetics, and toxicology is recommended.

20 January 2022 in Progress In Microbes & Molecular Biology
Verified
Journal Article
Open access
PDF file
MLMei Jun Loy
Mei Jun Loy
KGKhang Wen Goh
Khang Wen Goh
NONorliza Osili
Norliza Osili
Long MingLong Ming
Long Ming
SDSingh Dhaliwal
Singh Dhaliwal
KLKah Seng Lee
Kah Seng Lee
The study's objective was to assess the features and content of the COVID-19 mobile applications accessible in the Apple AppStore. A content analysis, comparison, and functionality evaluation of a few COVID-19 related mobile applications was performed. The search for COVID -19 related apps in the iOS AppStore took place between February 1 and March 31, 2022. The mobile applications received a maximum of 7 points (basic feature assessment) and 8 points overall (functionality assessment). The requirements were fully met by receiving one point. Frequencies from descriptive statistics were used to allude to the applications' features according to the app's basic purpose. A total of 234 applications were recognized using the keywords to exploreCOVID-19 related mobile applications in Apple AppStore. However, 58 mobile applications (24.8%) relevant to COVID-19 were evaluated. According to the findings of an evaluation of basic aspects of mobile applications, 89.7% require an internet connection, 70.7% have a size of less than 50 MB, 96.6% require no funding, 58.6% include educational content, and 60.3% offer advice from the applications. In terms of score, 41.4% scored three or below, whereas 58.6% scored four or above. Functionality assessment wise, 79.3% included information regarding COVID-19, 12.1% included COVID-19 contact tracing, 17.2% had vaccination status, a health authority maintained 50%, 31.0% included COVID-19 statistics, and 25.8% were able to report ART/PCR test. In terms of score, 91.4% scored three points or less, and 8.6% scored four points or more. This study has discovered several applications that could effectively prevent COVID-19 pandemic spread. Based on the findings, mobile applications that would be recommended are the ones supported by the government health administration of the respective country. App development companies’ applications show that competent healthcare personnel was not involved in developing the applications. Online consultation with healthcare professionals might help the public who do not have access to the nearest hospital.

1 January 2020 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
NHNurul Khaleeda Athiraah Hamdan
Nurul Khaleeda Athiraah Hamdan
QLQi Ying Lean
Qi Ying Lean
CNChin Fen Neoh
Chin Fen Neoh
AAAmir Heberd Abdullah
Amir Heberd Abdullah
SLSiong Meng Lim
Siong Meng Lim
PLPei Lin Lua
Pei Lin Lua
Introduction. Facial candling is a traditional method used for relieving symptoms of allergic rhinitis (AR). This study aims to investigate the knowledge and perception of facial candling in a sample of staff and students in a public university in Malaysia. Methods. An online questionnaire survey method was used. Based on sample size calculation, a total of 1,508 UiTM staff and students from ten selected campuses of Universiti Teknologi MARA (UiTM) were invited to participate in this survey. An up‐to‐date e‐mail list of staff in the selected campuses was used as the sampling frame for the study, whereas the students were recruited from the official university student Facebook portal. Results. A total of 788 respondents participated in this survey, 72.2% of them knew about facial candling, though only 35.4% had tried the treatment. Approximately one‐fifth of respondents agreed that facial candling might treat AR. It was found that a higher number of users than nonusers agreed that facial candling was a traditional medicine (78.9% vs 55.0%); could be used on the face and ears (83.5% vs 45.4%); and could be self‐administered at home (83.5 vs 45.4%). Interestingly, more than half of them were uncertain about its long‐term effects and adverse reactions. Conclusion. This study confirms the facial candling use among patients with AR although the percentage is low. The patients and general public need to be better informed about the use of facial candling in AR and its associated risks.

25 October 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
AKAMRITA KUMARI
AMRITA KUMARI
NRNeha Raina
Neha Raina
AWAbhishek Wahi
Abhishek Wahi
KGKhang Wen Goh
Khang Wen Goh
PSPratibha Sharma
Pratibha Sharma
MGMadhu Gupta
Madhu Gupta
Wound healing is an intricate process of tissue repair or remodeling that occurs in response to injury. Plants and plant-derived bioactive constituents are well explored in the treatment of various types of wounds. Curcumin is a natural polyphenolic substance that has been used since ancient times in Ayurveda for its healing properties, as it reduces inflammation and acts on several healing stages. Several research studies for curcumin delivery at the wound site reported the effectiveness of curcumin in eradicating reactive oxygen species and its ability to enhance the deposition of collagen, granulation tissue formation, and finally, expedite wound contraction. Curcumin has been widely investigated for its wound healing potential but its lower solubility and rapid metabolism, in addition to its shorter plasma half-life, have limited its applications in wound healing. As nanotechnology has proven to be an effective technique to accelerate wound healing by stimulating appropriate mobility through various healing phases, curcumin-loaded nanocarriers are used for targeted delivery at the wound sites. This review highlights the potential of curcumin and its nanoformulations, such as liposomes, nanoparticles, and nano-emulsions, etc. in wound healing. This paper emphasizes the numerous biomedical applications of curcumin which collectively prepare a base for its antibiofilm and wound-healing action.
1